nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTP1—bone cancer	0.319	0.756	CbGaD
Busulfan—GSTM1—Carboplatin—bone cancer	0.144	0.311	CbGbCtD
Busulfan—GSTM1—Cisplatin—bone cancer	0.123	0.266	CbGbCtD
Busulfan—GSTP1—Carboplatin—bone cancer	0.104	0.225	CbGbCtD
Busulfan—CYP3A4—bone cancer	0.103	0.244	CbGaD
Busulfan—GSTP1—Cisplatin—bone cancer	0.0889	0.192	CbGbCtD
Busulfan—GSTM1—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00303	0.0932	CbGpPWpGaD
Busulfan—MGST2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00244	0.075	CbGpPWpGaD
Busulfan—CYP3A4—Doxorubicin—bone cancer	0.00233	0.00505	CbGbCtD
Busulfan—GSTA1—Estrogen metabolism—CYP3A4—bone cancer	0.00216	0.0666	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP4V2—bone cancer	0.00209	0.0642	CbGpPWpGaD
Busulfan—GSTM1—Estrogen metabolism—CYP3A4—bone cancer	0.00142	0.0438	CbGpPWpGaD
Busulfan—MGST2—Glutathione conjugation—GSTP1—bone cancer	0.00137	0.0423	CbGpPWpGaD
Busulfan—GSTA1—Glutathione conjugation—GSTP1—bone cancer	0.00117	0.036	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP4V2—bone cancer	0.00117	0.0359	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP4V2—bone cancer	0.000991	0.0305	CbGpPWpGaD
Busulfan—GSTA2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000922	0.0284	CbGpPWpGaD
Busulfan—GSTA2—Glutathione conjugation—GSTP1—bone cancer	0.000789	0.0243	CbGpPWpGaD
Busulfan—GSTM1—Glutathione conjugation—GSTP1—bone cancer	0.000767	0.0236	CbGpPWpGaD
Busulfan—MGST2—Phase II conjugation—GSTP1—bone cancer	0.000611	0.0188	CbGpPWpGaD
Busulfan—GSTA1—Phase II conjugation—GSTP1—bone cancer	0.00052	0.016	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—CYP3A4—bone cancer	0.000418	0.0129	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—CYP3A4—bone cancer	0.000412	0.0127	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—TGFBR2—bone cancer	0.000408	0.0126	CbGpPWpGaD
Busulfan—MGST2—NRF2 pathway—GSTP1—bone cancer	0.000408	0.0126	CbGpPWpGaD
Busulfan—MGST2—Biological oxidations—GSTP1—bone cancer	0.000358	0.011	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—CYP3A4—bone cancer	0.000356	0.011	CbGpPWpGaD
Busulfan—MGST2—Metapathway biotransformation—GSTP1—bone cancer	0.000353	0.0109	CbGpPWpGaD
Busulfan—GSTA2—Phase II conjugation—GSTP1—bone cancer	0.000351	0.0108	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—GSTP1—bone cancer	0.000347	0.0107	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—TGFBR2—bone cancer	0.000347	0.0107	CbGpPWpGaD
Busulfan—GSTM1—Phase II conjugation—GSTP1—bone cancer	0.000342	0.0105	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000327	0.0101	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—BMI1—bone cancer	0.000318	0.00981	CbGpPWpGaD
Busulfan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000307	0.00946	CbGpPWpGaD
Busulfan—GSTA1—Biological oxidations—GSTP1—bone cancer	0.000304	0.00937	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000276	0.00849	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NDUFA12—bone cancer	0.000251	0.00772	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—KIT—bone cancer	0.000242	0.00745	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—CYP3A4—bone cancer	0.00024	0.0074	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—GSTP1—bone cancer	0.000234	0.00721	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—TGFBR2—bone cancer	0.000234	0.00721	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—CYP3A4—bone cancer	0.000234	0.0072	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—CYP3A4—bone cancer	0.00023	0.0071	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—TGFBR2—bone cancer	0.000228	0.00702	CbGpPWpGaD
Busulfan—GSTM1—NRF2 pathway—GSTP1—bone cancer	0.000228	0.00702	CbGpPWpGaD
Busulfan—GSTA2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000217	0.00667	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NDUFA12—bone cancer	0.000213	0.00656	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NT5C3A—bone cancer	0.000208	0.0064	CbGpPWpGaD
Busulfan—GSTA2—Biological oxidations—GSTP1—bone cancer	0.000205	0.00633	CbGpPWpGaD
Busulfan—GSTM1—Biological oxidations—GSTP1—bone cancer	0.0002	0.00615	CbGpPWpGaD
Busulfan—GSTP1—Biological oxidations—CYP3A4—bone cancer	0.000199	0.00612	CbGpPWpGaD
Busulfan—GSTM1—Metapathway biotransformation—GSTP1—bone cancer	0.000197	0.00607	CbGpPWpGaD
Busulfan—GSTP1—Metapathway biotransformation—CYP3A4—bone cancer	0.000196	0.00603	CbGpPWpGaD
Busulfan—GSTP1—NRF2 pathway—TGFBR2—bone cancer	0.000194	0.00597	CbGpPWpGaD
Busulfan—GSTM1—C-MYB transcription factor network—PTGS2—bone cancer	0.000184	0.00566	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NT5C3A—bone cancer	0.000177	0.00544	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000176	0.00544	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—EZH2—bone cancer	0.000155	0.00477	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NDUFA12—bone cancer	0.000144	0.00443	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000141	0.00433	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NDUFA12—bone cancer	0.00014	0.00431	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NT5C3A—bone cancer	0.000119	0.00367	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NDUFA12—bone cancer	0.000119	0.00367	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NT5C3A—bone cancer	0.000116	0.00357	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NT5C3A—bone cancer	9.87e-05	0.00304	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ENO2—bone cancer	9.1e-05	0.0028	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDK4—bone cancer	8.74e-05	0.00269	CbGpPWpGaD
Busulfan—Pancytopenia—Epirubicin—bone cancer	8.61e-05	0.00103	CcSEcCtD
Busulfan—Pain—Cisplatin—bone cancer	8.59e-05	0.00102	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Doxorubicin—bone cancer	8.56e-05	0.00102	CcSEcCtD
Busulfan—Renal failure—Methotrexate—bone cancer	8.5e-05	0.00101	CcSEcCtD
Busulfan—Dysuria—Epirubicin—bone cancer	8.48e-05	0.00101	CcSEcCtD
Busulfan—Neutropenia—Epirubicin—bone cancer	8.48e-05	0.00101	CcSEcCtD
Busulfan—Abdominal distension—Doxorubicin—bone cancer	8.45e-05	0.00101	CcSEcCtD
Busulfan—MGST2—Metabolism—DHFR—bone cancer	8.44e-05	0.0026	CbGpPWpGaD
Busulfan—Stomatitis—Methotrexate—bone cancer	8.42e-05	0.001	CcSEcCtD
Busulfan—Asthma—Doxorubicin—bone cancer	8.39e-05	0.000999	CcSEcCtD
Busulfan—Feeling abnormal—Cisplatin—bone cancer	8.28e-05	0.000986	CcSEcCtD
Busulfan—Weight increased—Epirubicin—bone cancer	8.25e-05	0.000983	CcSEcCtD
Busulfan—Haematuria—Methotrexate—bone cancer	8.24e-05	0.000981	CcSEcCtD
Busulfan—Pancreatitis—Doxorubicin—bone cancer	8.23e-05	0.00098	CcSEcCtD
Busulfan—Weight decreased—Epirubicin—bone cancer	8.21e-05	0.000977	CcSEcCtD
Busulfan—Hyperglycaemia—Epirubicin—bone cancer	8.18e-05	0.000974	CcSEcCtD
Busulfan—Hepatobiliary disease—Methotrexate—bone cancer	8.17e-05	0.000973	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—bone cancer	8.15e-05	0.000971	CcSEcCtD
Busulfan—Pneumonia—Epirubicin—bone cancer	8.13e-05	0.000969	CcSEcCtD
Busulfan—Infestation—Epirubicin—bone cancer	8.09e-05	0.000963	CcSEcCtD
Busulfan—Infestation NOS—Epirubicin—bone cancer	8.09e-05	0.000963	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—bone cancer	8.06e-05	0.00096	CcSEcCtD
Busulfan—Pancytopenia—Doxorubicin—bone cancer	7.97e-05	0.000949	CcSEcCtD
Busulfan—Renal failure—Epirubicin—bone cancer	7.95e-05	0.000947	CcSEcCtD
Busulfan—Body temperature increased—Cisplatin—bone cancer	7.94e-05	0.000946	CcSEcCtD
Busulfan—MGST2—Metabolism—GNA11—bone cancer	7.89e-05	0.00243	CbGpPWpGaD
Busulfan—Stomatitis—Epirubicin—bone cancer	7.88e-05	0.000939	CcSEcCtD
Busulfan—Jaundice—Epirubicin—bone cancer	7.88e-05	0.000939	CcSEcCtD
Busulfan—Neutropenia—Doxorubicin—bone cancer	7.85e-05	0.000935	CcSEcCtD
Busulfan—Dysuria—Doxorubicin—bone cancer	7.85e-05	0.000935	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—bone cancer	7.8e-05	0.000929	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—bone cancer	7.76e-05	0.000924	CcSEcCtD
Busulfan—GSTA1—Metabolism—ENO2—bone cancer	7.73e-05	0.00238	CbGpPWpGaD
Busulfan—Haematuria—Epirubicin—bone cancer	7.71e-05	0.000918	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—bone cancer	7.7e-05	0.000917	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—bone cancer	7.66e-05	0.000912	CcSEcCtD
Busulfan—Hepatobiliary disease—Epirubicin—bone cancer	7.65e-05	0.000911	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—bone cancer	7.64e-05	0.00091	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—bone cancer	7.63e-05	0.000908	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—bone cancer	7.6e-05	0.000906	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—RB1—bone cancer	7.6e-05	0.00234	CbGpPWpGaD
Busulfan—Weight decreased—Doxorubicin—bone cancer	7.59e-05	0.000904	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—bone cancer	7.59e-05	0.000904	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—bone cancer	7.57e-05	0.000902	CcSEcCtD
Busulfan—Agranulocytosis—Epirubicin—bone cancer	7.55e-05	0.000899	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—bone cancer	7.53e-05	0.000896	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—bone cancer	7.48e-05	0.000891	CcSEcCtD
Busulfan—Infestation—Doxorubicin—bone cancer	7.48e-05	0.000891	CcSEcCtD
Busulfan—Hypersensitivity—Cisplatin—bone cancer	7.4e-05	0.000881	CcSEcCtD
Busulfan—Bradycardia—Epirubicin—bone cancer	7.39e-05	0.00088	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—bone cancer	7.36e-05	0.000876	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—bone cancer	7.34e-05	0.000874	CcSEcCtD
Busulfan—Haemoglobin—Epirubicin—bone cancer	7.3e-05	0.000869	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—bone cancer	7.29e-05	0.000869	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—bone cancer	7.29e-05	0.000869	CcSEcCtD
Busulfan—Rhinitis—Epirubicin—bone cancer	7.28e-05	0.000867	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—bone cancer	7.26e-05	0.000865	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—bone cancer	7.25e-05	0.000863	CcSEcCtD
Busulfan—Asthenia—Cisplatin—bone cancer	7.21e-05	0.000858	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—bone cancer	7.21e-05	0.000858	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—bone cancer	7.2e-05	0.000857	CcSEcCtD
Busulfan—GSTA1—Metabolism—DHFR—bone cancer	7.18e-05	0.00221	CbGpPWpGaD
Busulfan—Urinary tract disorder—Epirubicin—bone cancer	7.17e-05	0.000854	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP3A4—bone cancer	7.15e-05	0.0022	CbGpPWpGaD
Busulfan—Haematuria—Doxorubicin—bone cancer	7.13e-05	0.00085	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—bone cancer	7.13e-05	0.00085	CcSEcCtD
Busulfan—Urethral disorder—Epirubicin—bone cancer	7.12e-05	0.000848	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—bone cancer	7.08e-05	0.000843	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—bone cancer	7.06e-05	0.000841	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—bone cancer	7.04e-05	0.000838	CcSEcCtD
Busulfan—Sinusitis—Doxorubicin—bone cancer	7.02e-05	0.000836	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—bone cancer	7.01e-05	0.000835	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—bone cancer	6.99e-05	0.000833	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—bone cancer	6.98e-05	0.000832	CcSEcCtD
Busulfan—Chills—Methotrexate—bone cancer	6.96e-05	0.000829	CcSEcCtD
Busulfan—Diarrhoea—Cisplatin—bone cancer	6.87e-05	0.000818	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—bone cancer	6.86e-05	0.000818	CcSEcCtD
Busulfan—Alopecia—Methotrexate—bone cancer	6.86e-05	0.000816	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—bone cancer	6.84e-05	0.000814	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—bone cancer	6.8e-05	0.000809	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—bone cancer	6.78e-05	0.000808	CcSEcCtD
Busulfan—Erythema—Methotrexate—bone cancer	6.75e-05	0.000804	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—bone cancer	6.75e-05	0.000804	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—bone cancer	6.75e-05	0.000804	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—bone cancer	6.74e-05	0.000802	CcSEcCtD
Busulfan—Flushing—Epirubicin—bone cancer	6.74e-05	0.000802	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—bone cancer	6.73e-05	0.000802	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—bone cancer	6.72e-05	0.0008	CcSEcCtD
Busulfan—GSTA1—Metabolism—GNA11—bone cancer	6.71e-05	0.00207	CbGpPWpGaD
Busulfan—Pharyngitis—Doxorubicin—bone cancer	6.67e-05	0.000794	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—bone cancer	6.63e-05	0.00079	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—bone cancer	6.6e-05	0.000786	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—bone cancer	6.59e-05	0.000784	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—bone cancer	6.59e-05	0.000784	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—bone cancer	6.56e-05	0.000781	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—bone cancer	6.54e-05	0.000779	CcSEcCtD
Busulfan—Back pain—Methotrexate—bone cancer	6.53e-05	0.000778	CcSEcCtD
Busulfan—Chills—Epirubicin—bone cancer	6.51e-05	0.000776	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—bone cancer	6.49e-05	0.000772	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—MDM2—bone cancer	6.48e-05	0.002	CbGpPWpGaD
Busulfan—Alopecia—Epirubicin—bone cancer	6.42e-05	0.000764	CcSEcCtD
Busulfan—Vomiting—Cisplatin—bone cancer	6.39e-05	0.000761	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—bone cancer	6.36e-05	0.000757	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—bone cancer	6.35e-05	0.000756	CcSEcCtD
Busulfan—Rash—Cisplatin—bone cancer	6.33e-05	0.000754	CcSEcCtD
Busulfan—Dermatitis—Cisplatin—bone cancer	6.33e-05	0.000754	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—bone cancer	6.32e-05	0.000753	CcSEcCtD
Busulfan—Erythema—Epirubicin—bone cancer	6.32e-05	0.000753	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—bone cancer	6.28e-05	0.000748	CcSEcCtD
Busulfan—Anaemia—Methotrexate—bone cancer	6.24e-05	0.000743	CcSEcCtD
Busulfan—Flushing—Doxorubicin—bone cancer	6.23e-05	0.000742	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—bone cancer	6.23e-05	0.000742	CcSEcCtD
Busulfan—Tension—Epirubicin—bone cancer	6.2e-05	0.000739	CcSEcCtD
Busulfan—Nervousness—Epirubicin—bone cancer	6.14e-05	0.000731	CcSEcCtD
Busulfan—MGST2—Metabolism—GSTP1—bone cancer	6.12e-05	0.00188	CbGpPWpGaD
Busulfan—Back pain—Epirubicin—bone cancer	6.11e-05	0.000728	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—bone cancer	6.09e-05	0.000726	CcSEcCtD
Busulfan—GSTA1—Metabolism—CYP3A4—bone cancer	6.08e-05	0.00187	CbGpPWpGaD
Busulfan—Immune system disorder—Doxorubicin—bone cancer	6.07e-05	0.000723	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—bone cancer	6.05e-05	0.000721	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—bone cancer	6.05e-05	0.00072	CcSEcCtD
Busulfan—Chills—Doxorubicin—bone cancer	6.03e-05	0.000718	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—bone cancer	6e-05	0.000715	CcSEcCtD
Busulfan—Nausea—Cisplatin—bone cancer	5.97e-05	0.000711	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—bone cancer	5.94e-05	0.000707	CcSEcCtD
Busulfan—Cough—Methotrexate—bone cancer	5.89e-05	0.000702	CcSEcCtD
Busulfan—Mental disorder—Doxorubicin—bone cancer	5.89e-05	0.000701	CcSEcCtD
Busulfan—Convulsion—Methotrexate—bone cancer	5.85e-05	0.000697	CcSEcCtD
Busulfan—Erythema—Doxorubicin—bone cancer	5.85e-05	0.000696	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—bone cancer	5.85e-05	0.000696	CcSEcCtD
Busulfan—Anaemia—Epirubicin—bone cancer	5.84e-05	0.000696	CcSEcCtD
Busulfan—Agitation—Epirubicin—bone cancer	5.81e-05	0.000692	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—bone cancer	5.75e-05	0.000685	CcSEcCtD
Busulfan—Chest pain—Methotrexate—bone cancer	5.75e-05	0.000685	CcSEcCtD
Busulfan—Myalgia—Methotrexate—bone cancer	5.75e-05	0.000685	CcSEcCtD
Busulfan—Tension—Doxorubicin—bone cancer	5.74e-05	0.000683	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	5.71e-05	0.00068	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—bone cancer	5.68e-05	0.000676	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—bone cancer	5.66e-05	0.000674	CcSEcCtD
Busulfan—Back pain—Doxorubicin—bone cancer	5.66e-05	0.000674	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—JUN—bone cancer	5.63e-05	0.00174	CbGpPWpGaD
Busulfan—Confusional state—Methotrexate—bone cancer	5.56e-05	0.000662	CcSEcCtD
Busulfan—Cough—Epirubicin—bone cancer	5.51e-05	0.000657	CcSEcCtD
Busulfan—Convulsion—Epirubicin—bone cancer	5.48e-05	0.000652	CcSEcCtD
Busulfan—Infection—Methotrexate—bone cancer	5.48e-05	0.000652	CcSEcCtD
Busulfan—Hypertension—Epirubicin—bone cancer	5.46e-05	0.00065	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—bone cancer	5.41e-05	0.000644	CcSEcCtD
Busulfan—Anaemia—Doxorubicin—bone cancer	5.4e-05	0.000644	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—bone cancer	5.4e-05	0.000643	CcSEcCtD
Busulfan—Myalgia—Epirubicin—bone cancer	5.38e-05	0.000641	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—bone cancer	5.38e-05	0.000641	CcSEcCtD
Busulfan—Chest pain—Epirubicin—bone cancer	5.38e-05	0.000641	CcSEcCtD
Busulfan—Agitation—Doxorubicin—bone cancer	5.37e-05	0.00064	CcSEcCtD
Busulfan—Anxiety—Epirubicin—bone cancer	5.36e-05	0.000639	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—bone cancer	5.35e-05	0.000638	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	5.34e-05	0.000636	CcSEcCtD
Busulfan—Dry mouth—Epirubicin—bone cancer	5.26e-05	0.000627	CcSEcCtD
Busulfan—Anorexia—Methotrexate—bone cancer	5.25e-05	0.000626	CcSEcCtD
Busulfan—Leukopenia—Doxorubicin—bone cancer	5.23e-05	0.000623	CcSEcCtD
Busulfan—GSTA2—Metabolism—ENO2—bone cancer	5.22e-05	0.00161	CbGpPWpGaD
Busulfan—Confusional state—Epirubicin—bone cancer	5.2e-05	0.000619	CcSEcCtD
Busulfan—GSTA1—Metabolism—GSTP1—bone cancer	5.2e-05	0.0016	CbGpPWpGaD
Busulfan—Oedema—Epirubicin—bone cancer	5.16e-05	0.000614	CcSEcCtD
Busulfan—Hypotension—Methotrexate—bone cancer	5.15e-05	0.000613	CcSEcCtD
Busulfan—Infection—Epirubicin—bone cancer	5.12e-05	0.00061	CcSEcCtD
Busulfan—Cough—Doxorubicin—bone cancer	5.1e-05	0.000608	CcSEcCtD
Busulfan—GSTM1—Metabolism—ENO2—bone cancer	5.08e-05	0.00157	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—bone cancer	5.07e-05	0.000603	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—bone cancer	5.06e-05	0.000602	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—bone cancer	5.05e-05	0.000601	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—bone cancer	5.05e-05	0.000601	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—bone cancer	5.03e-05	0.0006	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—bone cancer	5.02e-05	0.000598	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—bone cancer	5.01e-05	0.000597	CcSEcCtD
Busulfan—Insomnia—Methotrexate—bone cancer	4.99e-05	0.000594	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—bone cancer	4.98e-05	0.000593	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—bone cancer	4.98e-05	0.000593	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—bone cancer	4.98e-05	0.000593	CcSEcCtD
Busulfan—Anxiety—Doxorubicin—bone cancer	4.96e-05	0.000591	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.94e-05	0.000589	CcSEcCtD
Busulfan—Anorexia—Epirubicin—bone cancer	4.92e-05	0.000586	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—bone cancer	4.91e-05	0.000585	CcSEcCtD
Busulfan—Somnolence—Methotrexate—bone cancer	4.9e-05	0.000584	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—bone cancer	4.87e-05	0.00058	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—bone cancer	4.85e-05	0.000578	CcSEcCtD
Busulfan—GSTA2—Metabolism—DHFR—bone cancer	4.85e-05	0.00149	CbGpPWpGaD
Busulfan—Hypotension—Epirubicin—bone cancer	4.82e-05	0.000574	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—bone cancer	4.81e-05	0.000573	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—bone cancer	4.79e-05	0.000571	CcSEcCtD
Busulfan—Oedema—Doxorubicin—bone cancer	4.77e-05	0.000568	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—bone cancer	4.76e-05	0.000567	CcSEcCtD
Busulfan—Fatigue—Methotrexate—bone cancer	4.75e-05	0.000566	CcSEcCtD
Busulfan—Infection—Doxorubicin—bone cancer	4.74e-05	0.000565	CcSEcCtD
Busulfan—GSTM1—Metabolism—DHFR—bone cancer	4.71e-05	0.00145	CbGpPWpGaD
Busulfan—Pain—Methotrexate—bone cancer	4.71e-05	0.000561	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—bone cancer	4.7e-05	0.00056	CcSEcCtD
Busulfan—Nervous system disorder—Doxorubicin—bone cancer	4.68e-05	0.000557	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—bone cancer	4.67e-05	0.000557	CcSEcCtD
Busulfan—Insomnia—Epirubicin—bone cancer	4.67e-05	0.000556	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—bone cancer	4.66e-05	0.000555	CcSEcCtD
Busulfan—Skin disorder—Doxorubicin—bone cancer	4.64e-05	0.000552	CcSEcCtD
Busulfan—Dyspnoea—Epirubicin—bone cancer	4.6e-05	0.000548	CcSEcCtD
Busulfan—Somnolence—Epirubicin—bone cancer	4.59e-05	0.000546	CcSEcCtD
Busulfan—Anorexia—Doxorubicin—bone cancer	4.55e-05	0.000542	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—bone cancer	4.54e-05	0.000541	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—bone cancer	4.54e-05	0.000541	CcSEcCtD
Busulfan—GSTA2—Metabolism—GNA11—bone cancer	4.53e-05	0.0014	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Methotrexate—bone cancer	4.51e-05	0.000537	CcSEcCtD
Busulfan—Decreased appetite—Epirubicin—bone cancer	4.48e-05	0.000534	CcSEcCtD
Busulfan—Hypotension—Doxorubicin—bone cancer	4.46e-05	0.000531	CcSEcCtD
Busulfan—Gastrointestinal disorder—Epirubicin—bone cancer	4.45e-05	0.00053	CcSEcCtD
Busulfan—Fatigue—Epirubicin—bone cancer	4.45e-05	0.00053	CcSEcCtD
Busulfan—Pain—Epirubicin—bone cancer	4.41e-05	0.000525	CcSEcCtD
Busulfan—Constipation—Epirubicin—bone cancer	4.41e-05	0.000525	CcSEcCtD
Busulfan—GSTM1—Metabolism—GNA11—bone cancer	4.41e-05	0.00136	CbGpPWpGaD
Busulfan—Urticaria—Methotrexate—bone cancer	4.38e-05	0.000521	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—bone cancer	4.36e-05	0.000519	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—bone cancer	4.36e-05	0.000519	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.35e-05	0.000518	CcSEcCtD
Busulfan—GSTP1—Metabolism—ENO2—bone cancer	4.32e-05	0.00133	CbGpPWpGaD
Busulfan—Insomnia—Doxorubicin—bone cancer	4.32e-05	0.000514	CcSEcCtD
Busulfan—Dyspnoea—Doxorubicin—bone cancer	4.25e-05	0.000507	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—bone cancer	4.25e-05	0.000506	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—bone cancer	4.24e-05	0.000505	CcSEcCtD
Busulfan—Gastrointestinal pain—Epirubicin—bone cancer	4.22e-05	0.000502	CcSEcCtD
Busulfan—Dyspepsia—Doxorubicin—bone cancer	4.2e-05	0.0005	CcSEcCtD
Busulfan—Decreased appetite—Doxorubicin—bone cancer	4.15e-05	0.000494	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—bone cancer	4.12e-05	0.000491	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—bone cancer	4.11e-05	0.00049	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP3A4—bone cancer	4.11e-05	0.00127	CbGpPWpGaD
Busulfan—Urticaria—Epirubicin—bone cancer	4.1e-05	0.000488	CcSEcCtD
Busulfan—Pain—Doxorubicin—bone cancer	4.08e-05	0.000486	CcSEcCtD
Busulfan—Constipation—Doxorubicin—bone cancer	4.08e-05	0.000486	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—bone cancer	4.08e-05	0.000486	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—bone cancer	4.08e-05	0.000486	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—bone cancer	4.06e-05	0.000484	CcSEcCtD
Busulfan—GSTP1—Metabolism—DHFR—bone cancer	4.01e-05	0.00123	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP3A4—bone cancer	4e-05	0.00123	CbGpPWpGaD
Busulfan—Asthenia—Methotrexate—bone cancer	3.95e-05	0.000471	CcSEcCtD
Busulfan—Feeling abnormal—Doxorubicin—bone cancer	3.93e-05	0.000468	CcSEcCtD
Busulfan—Gastrointestinal pain—Doxorubicin—bone cancer	3.9e-05	0.000465	CcSEcCtD
Busulfan—Pruritus—Methotrexate—bone cancer	3.9e-05	0.000464	CcSEcCtD
Busulfan—Hypersensitivity—Epirubicin—bone cancer	3.8e-05	0.000453	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—bone cancer	3.79e-05	0.000452	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—bone cancer	3.77e-05	0.000449	CcSEcCtD
Busulfan—Body temperature increased—Doxorubicin—bone cancer	3.77e-05	0.000449	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—bone cancer	3.77e-05	0.000449	CcSEcCtD
Busulfan—GSTP1—Metabolism—GNA11—bone cancer	3.75e-05	0.00115	CbGpPWpGaD
Busulfan—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.72e-05	0.00115	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—bone cancer	3.72e-05	0.00115	CbGpPWpGaD
Busulfan—Asthenia—Epirubicin—bone cancer	3.7e-05	0.000441	CcSEcCtD
Busulfan—Pruritus—Epirubicin—bone cancer	3.65e-05	0.000435	CcSEcCtD
Busulfan—Dizziness—Methotrexate—bone cancer	3.64e-05	0.000434	CcSEcCtD
Busulfan—Diarrhoea—Epirubicin—bone cancer	3.53e-05	0.00042	CcSEcCtD
Busulfan—Hypersensitivity—Doxorubicin—bone cancer	3.52e-05	0.000419	CcSEcCtD
Busulfan—GSTA2—Metabolism—GSTP1—bone cancer	3.51e-05	0.00108	CbGpPWpGaD
Busulfan—Vomiting—Methotrexate—bone cancer	3.5e-05	0.000417	CcSEcCtD
Busulfan—Rash—Methotrexate—bone cancer	3.48e-05	0.000414	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—bone cancer	3.47e-05	0.000413	CcSEcCtD
Busulfan—Headache—Methotrexate—bone cancer	3.45e-05	0.000411	CcSEcCtD
Busulfan—Asthenia—Doxorubicin—bone cancer	3.42e-05	0.000408	CcSEcCtD
Busulfan—GSTM1—Metabolism—GSTP1—bone cancer	3.42e-05	0.00105	CbGpPWpGaD
Busulfan—Dizziness—Epirubicin—bone cancer	3.41e-05	0.000406	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP3A4—bone cancer	3.4e-05	0.00105	CbGpPWpGaD
Busulfan—Pruritus—Doxorubicin—bone cancer	3.38e-05	0.000402	CcSEcCtD
Busulfan—Vomiting—Epirubicin—bone cancer	3.28e-05	0.000391	CcSEcCtD
Busulfan—Nausea—Methotrexate—bone cancer	3.27e-05	0.00039	CcSEcCtD
Busulfan—Diarrhoea—Doxorubicin—bone cancer	3.27e-05	0.000389	CcSEcCtD
Busulfan—Rash—Epirubicin—bone cancer	3.25e-05	0.000387	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—bone cancer	3.25e-05	0.000387	CcSEcCtD
Busulfan—Headache—Epirubicin—bone cancer	3.23e-05	0.000385	CcSEcCtD
Busulfan—MGST2—Metabolism—PTGS2—bone cancer	3.17e-05	0.000976	CbGpPWpGaD
Busulfan—Dizziness—Doxorubicin—bone cancer	3.16e-05	0.000376	CcSEcCtD
Busulfan—Nausea—Epirubicin—bone cancer	3.06e-05	0.000365	CcSEcCtD
Busulfan—Vomiting—Doxorubicin—bone cancer	3.03e-05	0.000361	CcSEcCtD
Busulfan—Rash—Doxorubicin—bone cancer	3.01e-05	0.000358	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—bone cancer	3.01e-05	0.000358	CcSEcCtD
Busulfan—Headache—Doxorubicin—bone cancer	2.99e-05	0.000356	CcSEcCtD
Busulfan—Nausea—Doxorubicin—bone cancer	2.83e-05	0.000338	CcSEcCtD
Busulfan—GSTA1—Metabolism—PTGS2—bone cancer	2.69e-05	0.00083	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.41e-05	0.000743	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.38e-05	0.000732	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS2—bone cancer	1.82e-05	0.000561	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS2—bone cancer	1.77e-05	0.000545	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NDUFA12—bone cancer	1.69e-05	0.00052	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS2—bone cancer	1.51e-05	0.000464	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NT5C3A—bone cancer	1.4e-05	0.000431	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ENO2—bone cancer	6.13e-06	0.000189	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—DHFR—bone cancer	5.69e-06	0.000175	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GNA11—bone cancer	5.32e-06	0.000164	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTP1—bone cancer	4.12e-06	0.000127	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS2—bone cancer	2.14e-06	6.58e-05	CbGpPWpGaD
